<p>康耐視科技（NASDAQ: CGNX）正在準備於 2026 年 2 月 11 日發佈其季度財報。以下是投資者在公告前應注意的簡要概述。</p>
<p>分析師預計康耐視科技的 <strong>每股收益</strong>（EPS）為 0.20 美元。</p>
<p>康耐視科技的多頭希望聽到公司不僅超越了這一預期，還能提供積極的指引或下個季度的增長預測。</p>
<p>新投資者應注意，影響股票價格的往往不是盈利的超出或未達預期，而是指引（或預測）。</p>
<h3>過去財報概述</h3>
<p>在上一次財報發佈中，公司每股收益超出預期 0.07 美元，導致隨後的交易日股價下跌 12.92%。</p>
<p>以下是康耐視科技的過去表現及其價格變化：</p>
<table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 預估</strong></td>
<td align="right">0.26</td>
<td align="right">0.21</td>
<td align="right">0.13</td>
<td align="right">0.16</td>
</tr>
<tr>
<td><strong>EPS 實際</strong></td>
<td align="right">0.33</td>
<td align="right">0.25</td>
<td align="right">0.16</td>
<td align="right">0.20</td>
</tr>
<tr>
<td><strong>價格變化 %</strong></td>
<td align="right">-13.00</td>
<td align="right">21.00</td>
<td align="right">2.00</td>
<td align="right">-14.00</td>
</tr>
</tbody>
</table>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1770742881_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1770742881_0.png"/></p>
<h3>康耐視科技股票表現</h3>
<p>截至 2 月 9 日，康耐視科技的股票交易價格為 43.72 美元。在過去 52 周內，股價上漲了 12.03%。考慮到這些回報通常是積極的，長期股東在此次財報發佈前可能持樂觀態度。</p>
<h3>分析師對康耐視科技的見解</h3>
<p>對於投資者而言，瞭解市場情緒和行業預期至關重要。本分析提供了關於康耐視科技的最新見解。</p>
<p>康耐視科技共收到 4 個分析師評級，普遍評級為買入。平均一年期目標價為 45.25 美元，暗示潛在上漲 3.5%。</p>
<h3>分析同行的分析師評級</h3>
<p>在此比較中，我們探討了 Vontier、Mirion Technologies 和 Itron 這三家行業知名公司的分析師評級和平均一年期目標價，提供了它們相對錶現預期和市場定位的見解。</p>
<ul>
<li>分析師目前對 Vontier 的評級為跑輸大盤，平均一年期目標價為 40.0 美元，暗示潛在下跌 8.51%。</li>
<li>分析師目前對 Mirion Technologies 的評級為買入，平均一年期目標價為 30.33 美元，暗示潛在下跌 30.63%。</li>
<li>分析師目前對 Itron 的評級為買入，平均一年期目標價為 127.5 美元，暗示潛在上漲 191.63%。</li>
</ul>
<h3>同行指標總結</h3>
<p>在同行分析總結中，展示了 Vontier、Mirion Technologies 和 Itron 的關鍵指標，揭示了它們在行業中的相對地位，並提供了對其市場位置和比較表現的有價值見解。</p>
<table>
<thead>
<tr>
<th>公司</th>
<th>共識</th>
<th>收入增長</th>
<th>毛利潤</th>
<th>股東權益回報率</th>
</tr>
</thead>
<tbody>
<tr>
<td>康耐視科技</td>
<td>買入</td>
<td>17.96%</td>
<td>1.8729 億美元</td>
<td>1.18%</td>
</tr>
<tr>
<td>Vontier</td>
<td>跑輸大盤</td>
<td>0.33%</td>
<td>3.5610 億美元</td>
<td>8.45%</td>
</tr>
<tr>
<td>Mirion Technologies</td>
<td>買入</td>
<td>7.88%</td>
<td>1.0450 億美元</td>
<td>0.18%</td>
</tr>
<tr>
<td>Itron</td>
<td>買入</td>
<td>-5.50%</td>
<td>2.1954 億美元</td>
<td>3.97%</td>
</tr>
</tbody>
</table>
<p>關鍵要點：</p>
<p>康耐視科技在同行中收入增長排名最高，但毛利潤和股東權益回報率最低。</p>
<h3>更深入瞭解康耐視科技</h3>
<p>康耐視科技提供機器視覺產品，幫助自動化製造過程。公司的產品包括視覺軟件、視覺系統、視覺傳感器和識別產品。視覺軟件將視覺工具與客户的攝像頭和外圍設備結合在一起，可以幫助完成多個視覺任務，包括零件定位、識別、測量和機器人引導。視覺系統將攝像頭、處理器和視覺軟件整合為一個整體。視覺傳感器為常見視覺應用提供簡單、低成本的解決方案，例如檢查零件的尺寸。識別產品讀取在製造過程中應用於物品上的代碼。康耐視科技在美國和歐洲的銷售佔比最大。</p>
<h3>理解數字：康耐視科技的財務狀況</h3>
<p><strong>市值：</strong> 公司市值較高，超過行業平均水平。這表明其規模龐大且市場認可度強。</p>
<p><strong>收入增長：</strong> 康耐視科技在 3 個月內的表現顯著。截至 2025 年 9 月 30 日，公司實現了 <strong>17.96%</strong> 的收入增長率。這表明公司頂線收益有了顯著增加。與同行相比，公司實現的增長率高於信息技術行業的平均水平。</p>
<p><strong>淨利潤率：</strong> 康耐視科技的淨利潤率令人印象深刻，超過行業平均水平。淨利潤率為 <strong>6.38%</strong>，顯示出強大的盈利能力和有效的成本管理。</p>
<p><strong>股東權益回報率（ROE）：</strong> 康耐視科技的 ROE 超越行業基準，達到 <strong>1.18%</strong>。這表明其財務管理穩健，股東權益資本的使用效率高。</p>
<p><strong>資產回報率（ROA）：</strong> 康耐視科技的 ROA 超越行業基準，達到 <strong>0.88%</strong>。這表明其資產管理高效，財務狀況良好。</p>
<p><strong>債務管理：</strong> 康耐視科技的債務與股本比率低於行業平均水平。比率為 <strong>0.05</strong>，公司對債務融資的依賴較小，保持了債務與股本之間更健康的平衡，這對投資者來説是一個積極的信號。</p>
<p>要跟蹤康耐視科技的所有財報發佈，請訪問我們網站上的財報日曆。</p>
<p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>

全球科技股指數 ETF - iShares

IBOT

Global X 機器人工智能ETF

工業創新 ETF - ARK

康耐視科技

全球機器人自動化 ETF - ROBO

<p>康耐視科技（NASDAQ:CGNX）定於 2026 年 2 月 11 日公佈季度財報，分析師預測每股收益（EPS）為 0.20 美元。投資者對未來增長的積極指引充滿期待。過去，康耐視科技的盈利超預期曾導致股價下跌 12.92%。目前，股價為 43.72 美元，過去一年上漲了 12.03%。分析師對康耐視科技的評級為 “買入”，一年目標價為 45.25 美元。該公司顯示出強勁的收入增長，達到 17.96%，並維持低債務股本比率為 0.05，表明其財務健康狀況良好</p>

<p>Cognex (NASDAQ: CGNX) is preparing to release its quarterly earnings on Wednesday, 2026-02-11. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<div class="lb-trans"><p>康耐視科技（NASDAQ: CGNX）正在準備於 2026 年 2 月 11 日發佈其季度財報。以下是投資者在公告前應注意的簡要概述。</p>
</div><p>Analysts expect Cognex to report an <strong>earnings per share</strong> (EPS) of $0.20.</p>
<div class="lb-trans"><p>分析師預計康耐視科技的 <strong>每股收益</strong>（EPS）為 0.20 美元。</p>
</div><p>Cognex bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<div class="lb-trans"><p>康耐視科技的多頭希望聽到公司不僅超越了這一預期，還能提供積極的指引或下個季度的增長預測。</p>
</div><p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<div class="lb-trans"><p>新投資者應注意，影響股票價格的往往不是盈利的超出或未達預期，而是指引（或預測）。</p>
</div><h3>Overview of Past Earnings</h3>
<div class="lb-trans"><h3>過去財報概述</h3>
</div><p>In the previous earnings release, the company beat EPS by $0.07, leading to a 12.92% drop in the share price the following trading session.</p>
<div class="lb-trans"><p>在上一次財報發佈中，公司每股收益超出預期 0.07 美元，導致隨後的交易日股價下跌 12.92%。</p>
</div><p>Here's a look at Cognex's past performance and the resulting price change:</p>
<div class="lb-trans"><p>以下是康耐視科技的過去表現及其價格變化：</p>
</div><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
<th align="right"><strong>Q2 2025</strong></th>
<th align="right"><strong>Q1 2025</strong></th>
<th align="right"><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">0.26</td>
<td align="right">0.21</td>
<td align="right">0.13</td>
<td align="right">0.16</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">0.33</td>
<td align="right">0.25</td>
<td align="right">0.16</td>
<td align="right">0.20</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">-13.00</td>
<td align="right">21.00</td>
<td align="right">2.00</td>
<td align="right">-14.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 預估</strong></td>
<td align="right">0.26</td>
<td align="right">0.21</td>
<td align="right">0.13</td>
<td align="right">0.16</td>
</tr>
<tr>
<td><strong>EPS 實際</strong></td>
<td align="right">0.33</td>
<td align="right">0.25</td>
<td align="right">0.16</td>
<td align="right">0.20</td>
</tr>
<tr>
<td><strong>價格變化 %</strong></td>
<td align="right">-13.00</td>
<td align="right">21.00</td>
<td align="right">2.00</td>
<td align="right">-14.00</td>
</tr>
</tbody>
</table>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1770742881_0.png" alt="eps graph" original-src="https://www.benzinga.com/files/images/story/2026/1770742881_0.png"/></p>
<h3>Performance of Cognex Shares</h3>
<div class="lb-trans"><h3>康耐視科技股票表現</h3>
</div><p>Shares of Cognex were trading at $43.72 as of February 09. Over the last 52-week period, shares are up 12.03%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.</p>
<div class="lb-trans"><p>截至 2 月 9 日，康耐視科技的股票交易價格為 43.72 美元。在過去 52 周內，股價上漲了 12.03%。考慮到這些回報通常是積極的，長期股東在此次財報發佈前可能持樂觀態度。</p>
</div><h3>Analyst Insights on Cognex</h3>
<div class="lb-trans"><h3>分析師對康耐視科技的見解</h3>
</div><p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Cognex.</p>
<div class="lb-trans"><p>對於投資者而言，瞭解市場情緒和行業預期至關重要。本分析提供了關於康耐視科技的最新見解。</p>
</div><p>A total of 4 analyst ratings have been received for Cognex, with the consensus rating being Buy. The average one-year price target stands at $45.25, suggesting a potential 3.5% upside.</p>
<div class="lb-trans"><p>康耐視科技共收到 4 個分析師評級，普遍評級為買入。平均一年期目標價為 45.25 美元，暗示潛在上漲 3.5%。</p>
</div><h3>Analyzing Analyst Ratings Among Peers</h3>
<div class="lb-trans"><h3>分析同行的分析師評級</h3>
</div><p>In this comparison, we explore the analyst ratings and average 1-year price targets of Vontier, Mirion Technologies and Itron, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<div class="lb-trans"><p>在此比較中，我們探討了 Vontier、Mirion Technologies 和 Itron 這三家行業知名公司的分析師評級和平均一年期目標價，提供了它們相對錶現預期和市場定位的見解。</p>
</div><ul>
<li>Analysts currently favor an Underperform trajectory for Vontier, with an average 1-year price target of $40.0, suggesting a potential 8.51% downside.</li>
<li>Analysts currently favor an Buy trajectory for Mirion Technologies, with an average 1-year price target of $30.33, suggesting a potential 30.63% downside.</li>
<li>Analysts currently favor an Buy trajectory for Itron, with an average 1-year price target of $127.5, suggesting a potential 191.63% upside.</li>
</ul>
<div class="lb-trans"><ul>
<li>分析師目前對 Vontier 的評級為跑輸大盤，平均一年期目標價為 40.0 美元，暗示潛在下跌 8.51%。</li>
<li>分析師目前對 Mirion Technologies 的評級為買入，平均一年期目標價為 30.33 美元，暗示潛在下跌 30.63%。</li>
<li>分析師目前對 Itron 的評級為買入，平均一年期目標價為 127.5 美元，暗示潛在上漲 191.63%。</li>
</ul>
</div><h3>Peer Metrics Summary</h3>
<div class="lb-trans"><h3>同行指標總結</h3>
</div><p>Within the peer analysis summary, vital metrics for Vontier, Mirion Technologies and Itron are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<div class="lb-trans"><p>在同行分析總結中，展示了 Vontier、Mirion Technologies 和 Itron 的關鍵指標，揭示了它們在行業中的相對地位，並提供了對其市場位置和比較表現的有價值見解。</p>
</div><table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cognex</td>
<td>Buy</td>
<td>17.96%</td>
<td>$187.29M</td>
<td>1.18%</td>
</tr>
<tr>
<td>Vontier</td>
<td>Underperform</td>
<td>0.33%</td>
<td>$356.10M</td>
<td>8.45%</td>
</tr>
<tr>
<td>Mirion Technologies</td>
<td>Buy</td>
<td>7.88%</td>
<td>$104.50M</td>
<td>0.18%</td>
</tr>
<tr>
<td>Itron</td>
<td>Buy</td>
<td>-5.50%</td>
<td>$219.54M</td>
<td>3.97%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>公司</th>
<th>共識</th>
<th>收入增長</th>
<th>毛利潤</th>
<th>股東權益回報率</th>
</tr>
</thead>
<tbody>
<tr>
<td>康耐視科技</td>
<td>買入</td>
<td>17.96%</td>
<td>1.8729 億美元</td>
<td>1.18%</td>
</tr>
<tr>
<td>Vontier</td>
<td>跑輸大盤</td>
<td>0.33%</td>
<td>3.5610 億美元</td>
<td>8.45%</td>
</tr>
<tr>
<td>Mirion Technologies</td>
<td>買入</td>
<td>7.88%</td>
<td>1.0450 億美元</td>
<td>0.18%</td>
</tr>
<tr>
<td>Itron</td>
<td>買入</td>
<td>-5.50%</td>
<td>2.1954 億美元</td>
<td>3.97%</td>
</tr>
</tbody>
</table>
</div><p>Key Takeaway:</p>
<div class="lb-trans"><p>關鍵要點：</p>
</div><p>Cognex ranks highest in Revenue Growth among its peers. It has the lowest Gross Profit and Return on Equity.</p>
<div class="lb-trans"><p>康耐視科技在同行中收入增長排名最高，但毛利潤和股東權益回報率最低。</p>
</div><h3>Get to Know Cognex Better</h3>
<div class="lb-trans"><h3>更深入瞭解康耐視科技</h3>
</div><p>Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.</p>
<div class="lb-trans"><p>康耐視科技提供機器視覺產品，幫助自動化製造過程。公司的產品包括視覺軟件、視覺系統、視覺傳感器和識別產品。視覺軟件將視覺工具與客户的攝像頭和外圍設備結合在一起，可以幫助完成多個視覺任務，包括零件定位、識別、測量和機器人引導。視覺系統將攝像頭、處理器和視覺軟件整合為一個整體。視覺傳感器為常見視覺應用提供簡單、低成本的解決方案，例如檢查零件的尺寸。識別產品讀取在製造過程中應用於物品上的代碼。康耐視科技在美國和歐洲的銷售佔比最大。</p>
</div><h3>Understanding the Numbers: Cognex's Finances</h3>
<div class="lb-trans"><h3>理解數字：康耐視科技的財務狀況</h3>
</div><p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<div class="lb-trans"><p><strong>市值：</strong> 公司市值較高，超過行業平均水平。這表明其規模龐大且市場認可度強。</p>
</div><p><strong>Revenue Growth:</strong> Cognex's remarkable performance in 3 months is evident. As of 30 September, 2025, the company achieved an impressive revenue growth rate of <strong>17.96%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.</p>
<div class="lb-trans"><p><strong>收入增長：</strong> 康耐視科技在 3 個月內的表現顯著。截至 2025 年 9 月 30 日，公司實現了 <strong>17.96%</strong> 的收入增長率。這表明公司頂線收益有了顯著增加。與同行相比，公司實現的增長率高於信息技術行業的平均水平。</p>
</div><p><strong>Net Margin:</strong> Cognex's net margin is impressive, surpassing industry averages. With a net margin of <strong>6.38%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<div class="lb-trans"><p><strong>淨利潤率：</strong> 康耐視科技的淨利潤率令人印象深刻，超過行業平均水平。淨利潤率為 <strong>6.38%</strong>，顯示出強大的盈利能力和有效的成本管理。</p>
</div><p><strong>Return on Equity (ROE):</strong> Cognex's ROE excels beyond industry benchmarks, reaching <strong>1.18%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<div class="lb-trans"><p><strong>股東權益回報率（ROE）：</strong> 康耐視科技的 ROE 超越行業基準，達到 <strong>1.18%</strong>。這表明其財務管理穩健，股東權益資本的使用效率高。</p>
</div><p><strong>Return on Assets (ROA):</strong> Cognex's ROA excels beyond industry benchmarks, reaching <strong>0.88%</strong>. This signifies efficient management of assets and strong financial health.</p>
<div class="lb-trans"><p><strong>資產回報率（ROA）：</strong> 康耐視科技的 ROA 超越行業基準，達到 <strong>0.88%</strong>。這表明其資產管理高效，財務狀況良好。</p>
</div><p><strong>Debt Management:</strong> Cognex's debt-to-equity ratio is below the industry average. With a ratio of <strong>0.05</strong>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<div class="lb-trans"><p><strong>債務管理：</strong> 康耐視科技的債務與股本比率低於行業平均水平。比率為 <strong>0.05</strong>，公司對債務融資的依賴較小，保持了債務與股本之間更健康的平衡，這對投資者來説是一個積極的信號。</p>
</div><p>To track all earnings releases for Cognex visit their earnings calendar on our site.</p>
<div class="lb-trans"><p>要跟蹤康耐視科技的所有財報發佈，請訪問我們網站上的財報日曆。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>
</div>

康耐視科技的財報預期